Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Total number of shares and voting rights in Zealand Pharma as of September 30, 2026
Company announcement – No. 51 / 2026 Total number of shares and voting rights in Zealand Pharma as of September 30, 2026 Copenhagen, Denmark, September 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or 'the Company')…
Eric Cantor named new president of pharma trade group
PhRMA, the leading lobbying and trade organization for the U.S. pharmaceutical industry, announced Tuesday that former Republican House Majority Leader Eric Cantor will be taking over as its president. It has been over 10 years since the former…
Big pharma move to dispense GLP-1s to your door condemned by doctors
Eli Lilly's new online platform LillyDirect will dispense certain medicines, starting with Mounjaro, directly to a patient's door. Doctors and pharmacists have criticised the move, arguing it poses a risk to patient safety. Eli Lilly has defended…
Letter: Federal ban on imported prescription drugs serves only Big Pharma
You have permission to edit this article. Get up-to-the-minute news sent straight to your device.
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in…
Big Pharma Got Its Tariff Exemption. The Biotech ETF Barely Blinked
The second phase of the Section 232 tariff on imported patented drugs and their key ingredients began on September 29, 2026. That extended a duty that has covered a first group of named companies since July 31, 2026, to every other drugmaker. The…
Avalyn Pharma (NASDAQ:AVLN) Stock Jumps 6.4% - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares were up 6.4% on Wednesday. The stock traded as high as $28.87 and last traded at $28.84. 160,187 shares changed hands during trading, a decline of 48% from the average daily volume of…
GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma
Aurobindo Pharma on Tuesday said the Telangana GST appellate authority has upheld a demand for reversal of excess input tax credit claim totalling ₹4.60 crore. The order was passed by the Appellate Joint Commissioner (ST), Malkajgiri…
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 4,126 shares of the company's stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of $57.88, for a total value of…
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success (NASDAQ:AQST)
Aquestive Therapeutics offers a differentiated epinephrine product, Anaphylm, but faces pricing and market share headwinds. My base case values AQST at $8, reflecting ~70% upside, but I would only buy closer to $3.50 for an adequate margin of…
ALK expands strategic tablet supply partnership with Catalent
Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% to 1.1 billion tablets annually from early 2030s.
Indian Stock Markets Decline: Nifty Down 96 Points, Sensex Slips to 72,480 Amid Global Concerns
Indian stock markets, including the Sensex and Nifty, experienced their third consecutive day of declines, influenced by rising crude oil prices, high global bond yields, and substantial foreign fund outflows, prompting investor caution. Indian…
Eli Lilly's Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
An investigational combination therapy from Eli Lilly led to significant weight loss in a mid-stage study, but high rates of people stopping the treatment may raise questions about its tolerability. Lilly, which is racing to bring next-generation…
Sensex, Nifty Rebound: Easing Crude Prices & IT Stocks Drive Market Recovery
Indian benchmark indices Sensex and Nifty saw a positive rebound in early trade, driven by a moderation in crude oil prices and robust buying in key IT sector stocks, offering relief after two consecutive days of losses. The Sensex advanced 190…
Novo Nordisk: The Street Sold It For The Wrong Reason (NYSE:NVO)
Novo Nordisk trades at a discount to sector earnings multiples but appears expensive on free cash flow due to elevated capex. Management's guidance to normalize capex by 2030 is pivotal; free cash flow could rise from DKK 50B to DKK 125B, unlocking…
Receive a Daily briefing on Pharma Industry News
Get Started